Active Ingredient(s):Alcaftadine FDA Approved: * July 28, 2010 Pharm Company: *VISTAKON PHARMA Category:Vision / Eye Health
Alcaftadine is used to prevent eye irritation brought on by allergic conjunctivitis. It is a H1 histamine receptor antagonist.
It was approved by the U.S. Food and Drug Administration (FDA) in July 2010, under the trade name Lastacaft.
2 Clinical relevance
3 Adverse effects
6 See also
8 External links
Alcaftadine is an antagonist at three of the histamine receptors (1, 2 a...
* May have multiple approval dates, manufacturers, or labelers.